EQS-News: Race Oncology Ltd
Race Oncology welcomes positive pre-IND meeting for Zantrene
24.11.2022 / 17:20 CET/CEST
The issuer is solely responsible for the content of this announcement.
24.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
|
Language: |
English |
Company: |
Race Oncology Ltd |
|
|
|
|
|
United States |
ISIN: |
AU000000RAC3 |
EQS News ID: |
1496749 |
|
End of News |
EQS News Service |
1496749 24.11.2022 CET/CEST